GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: AMG203 [5] | MT203
Compound class:
Antibody
Comment: Namilumab (AMG203, MT203) is an IgG1κ anti-macrophage colony-stimulating factor (GM-CSF; CSF2) monoclonal antibody [2]. It is being developed by Micromet and Nycomed for the treatment of autoimmune and chronic inflammatory diseases.
Peptide sequences and structural information for this antibody are available from its IMGT/mAb-DB entry. |
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 9382 | namilumab |
Synonyms ![]() |
|
| AMG203 [5] | MT203 | |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 367 |
| Other databases | |
| GtoPdb PubChem SID | 384403650 |
| Search PubMed clinical trials | namilumab |
| Search PubMed titles | namilumab |
| Search PubMed titles/abstracts | namilumab |